Skip to main content

BlackRock, Inc.

Position in MRK — Merck & Co., Inc.

CIK 2012383 New York, NY

Position in MRK

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$29,169,479,049
+$2,004,348,666 QoQ
Shares Held
226,999,837
+0.5% QoQ
Ownership
9.20%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#1
of 3,778 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Mar 31, 2026
CallValue
$11,547,840
CallShares
96,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $263,330,305,956 across 19 Drug Manufacturers - General names. MRK ranks #4 (11.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 MRK
Merck & Co., Inc.
This page
226,999,837 $29,169,479,049

All Filings in MRK

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,169,479,049 226,999,837
2026-03-31 $11,547,840 96,000
2026-03-31 $27,165,130,383 225,830,330
2025-12-31 $23,061,988,634 219,095,465
2025-09-30 $18,034,593,026 214,876,600
2025-06-30 $17,283,860,254 218,340,832
2025-03-31 $20,231,745,202 225,398,231
2024-12-31 $22,092,701,931 222,081,845
2024-09-30 $24,081,503,721 212,059,737
2024-09-30 $104,815,880 923,000